Diabetes Clinical Trials in San Antonio

Showing 61-80 of 432 trials

A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM

NCT05761301

To evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single ascending doses of ALN-KHK and to evaluate the safety, tolerability, efficacy, PK and PD of multiple doses of KHK.

Type 2 Diabetes Mellitus (T2DM)

Alnylam Pharmaceuticals49 participantsStarted Mar 2023

Phoenix, Arizona, United States • Vista, California, United States • Lake Worth, Florida, United States +12 more locations

COMPLETEDPhase 3< 1 mile

A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes Mellitus

NCT03170518

The purpose of this study is to assess the effect of canagliflozin relative to placebo on glycated hemoglobin (HbA1c) after 26 weeks of treatment, and to assess the overall safety and tolerability of canagliflozin.

Diabetes Mellitus, Type 2

Janssen Research & Development, LLC171 participantsStarted Jul 2017

Little Rock, Arkansas, United States • Sacramento, California, United States • Whittier, California, United States +103 more locations

A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM

A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes Mellitus

Diabetes Trials in Other Cities

A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide Tablets

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients

Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System

A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)

Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM

Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity

Effect of Ketogenic Diet on Glucose Metabolism and Energy Expenditure in Type 2 Diabetes

Gan & Lee Insulin Glargine Target Type (1) Evaluating Research

Effect of Dapagliflozin on Hepatic and Renal Glucose Metabolism Subjects

Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

Pilot Study of Brief Intervention to Support Diabetes Health-Related Quality of Life

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

MIRACLE of LIFE Study

HbA1c Variation Study

C-myc Biomarker Study for Diabetic Foot Ulcers

A Phase 1 Study of DD01 in Overweight/Obese Subjects With T2DM and NAFLD

Other Conditions in San Antonio